Cerevel Therapeutics Holdings Inc (CERE)
$42.55
Insights on Cerevel Therapeutics Holdings Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 50.8% return, outperforming this stock by 19.9%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 231.7% return, outperforming this stock by 22.9%
Performance
- $42.54$42.71$42.55
0.02%
Downside
Day's Volatility :0.4%
Upside
0.37%
- $19.59$43.59$42.55
53.96%
Downside
52 Weeks Volatility :55.06%
Upside
2.39%
Returns
| Period | Cerevel Therapeutics Holdings Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | 2.14% | -2.2% | 0.0% |
6 Months | 70.47% | 9.8% | 0.0% |
1 Year | 29.96% | 5.4% | 0.5% |
3 Years | 208.78% | 14.3% | -21.1% |
Highlights
Market Capitalization | 7.6B |
Book Value | $3.72 |
Earnings Per Share (EPS) | -2.67 |
Wall Street Target Price | 43.4 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -24.73% |
Return On Equity TTM | -72.44% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -441.6M |
Diluted Eps TTM | -2.67 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -2.49 |
EPS Estimate Next Year | -2.81 |
EPS Estimate Current Quarter | -0.59 |
EPS Estimate Next Quarter | -0.59 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 2.0%
Technicals Summary
Sell
Neutral
Buy
Cerevel Therapeutics Holdings Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Cerevel Therapeutics Holdings Inc | 0.81% | 70.47% | 29.96% | 208.78% | 330.67% |
 Moderna, Inc. | 18.95% | 73.44% | -5.12% | -22.12% | 361.25% |
 Regeneron Pharmaceuticals, Inc. | 1.97% | 14.97% | 27.24% | 91.91% | 178.01% |
 Novo Nordisk A/s | -3.46% | 21.74% | 46.11% | 231.67% | 415.39% |
 Vertex Pharmaceuticals Incorporated | -0.78% | 3.97% | 16.56% | 88.16% | 129.5% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Cerevel Therapeutics Holdings Inc | NA | NA | NA | -2.49 | -0.72 | -0.25 | NA | 3.72 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.22 | -0.29 | -0.12 | NA | 36.27 |
Regeneron Pharmaceuticals, Inc. | 26.04 | 26.04 | 1.46 | 45.0 | 0.16 | 0.08 | NA | 242.47 |
Novo Nordisk A/s | 47.43 | 47.43 | 2.4 | 3.35 | 0.88 | 0.23 | 0.01 | 23.9 |
Vertex Pharmaceuticals Incorporated | 28.81 | 28.81 | 0.53 | 16.75 | 0.23 | 0.13 | NA | 68.22 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Cerevel Therapeutics Holdings Inc | Buy | $7.6B | 330.67% | NA | 0.0% |
Moderna, Inc. | Buy | $41.7B | 361.25% | 24.73 | -68.84% |
Regeneron Pharmaceuticals, Inc. | Buy | $99.5B | 178.01% | 26.04 | 30.14% |
Novo Nordisk A/s | Buy | $562.8B | 415.39% | 47.43 | 36.03% |
Vertex Pharmaceuticals Incorporated | Buy | $103.6B | 129.5% | 28.81 | 36.68% |
Institutional Holdings
Bain Capital Investors LLC
36.17%Perceptive Advisors LLC
6.04%FMR Inc
5.34%venBio Select Advisor LLC
4.16%Vanguard Group Inc
4.06%BlackRock Inc
3.32%
Corporate Announcements
Cerevel Therapeutics Holdings Inc Earnings
Cerevel Therapeutics Holdings Inc’s price-to-earnings ratio stands at None
Read More
Company Information
cerevel therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (cns). the company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of cns disorders, including parkinson’s, alzheimer’s, epilepsy, schizophrenia and addiction. headquartered in the greater boston area, cerevel was formed in 2018 through a partnership between bain capital and pfizer.
Organization | Cerevel Therapeutics Holdings Inc |
Employees | 334 |
CEO | Dr. N. Anthony Coles Jr., M.P.H. |
Industry | Finance |
Discover More
Royalty Pharma Plc
$42.55
-0.09%
Grupo Aeroportuario Del Sureste, Sabdecv
$42.55
-0.09%
Roku, Inc.
$42.55
-0.09%
Stag Industrial, Inc.
$42.55
-0.09%
Janus Henderson Group Plc
$42.55
-0.09%
Federal Realty Investment Trust
$42.55
-0.09%
Manpowergroup Inc.
$42.55
-0.09%
Brf S.a.
$42.55
-0.09%
Amn Healthcare Services Inc.
$42.55
-0.09%